# OnCo record da-trial-trailrunner-alz3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/da-trial-trailrunner-alz3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "da-trial-trailrunner-alz3", "NCT06653153" ;
  schema:name "TRAILRUNNER-ALZ 3"@en ;
  schema:description "TRAILRUNNER-ALZ 3 is a Phase 3 programme for remternetug. Recruiting status changes; check ClinicalTrials.gov."@en ;
  schema:url <https://onco.cc/trials/da-trial-trailrunner-alz3/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06653153> ;
  onco:status "recruiting" ;
  onco:tag "dementia-atlas" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/diagnoses/alzheimers-disease/> ;
  onco:drugs <https://onco.cc/drugs/da-remternetug/> ;
  onco:companies <https://onco.cc/companies/da-lilly/> .